Glutamine synthetase loss in β-catenin-mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogramming.

Journal:

Hepatology

Published:

2025-10-24

DOI:

10.1097/hep.0000000000001591

Affiliations:

7

Authors:

17

Go to article

Institutions	Authors	Share
Health Sciences, Pitt, United States of America (USA)	10.933333 10.933333	0.64
Pittsburgh Liver Research Center, United States of America (USA)	4.200000	0.25
University of Hawaiʻi Cancer Center, United States of America (USA)	1.000000	0.06
UPMC Hillman Cancer Center (UPCI), United States of America (USA)	0.866667	0.05

Interested in Medical Biochemistry and Metabolomics?